Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 3/20 | 0.34 |
| ▸ | SLC6A4 known ✓ | P31645 | 2/20 | 0.34 |
| ▸ | KCNH2 known ✓ | Q12809 | 2/20 | 0.34 |
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 known ✓ | P47870 | 1/20 | 0.33 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7748984 | 0.90 | SLC6A2 (0.32) | SLC6A2SLC6A4KCNH2GABRA1GABRB2 | |
| Hydrochloric Acid SCHEMBL512162 | 0.90 | GABRA1 (0.33) | GABRA1GABRB2 | |
| SCHEMBL1013751 | 0.88 | GABRA1 (0.34) | GABRA1GABRB2RIPK1 | |
| Hydrochloric Acid SCHEMBL1858922 | 0.80 | GABRA1 (0.31) | GABRA1GABRB2 | |
| Hydrochloric Acid SCHEMBL11607442 | 0.80 | GABRA1 (0.30) | GABRA1GABRB2 | |
| SCHEMBL25267340 | 0.79 | GABRA1 (0.31) | GABRA1GABRB2 | |
| SCHEMBL2436484 | 0.72 | — | — | |
| SCHEMBL10160283 | 0.72 | SLC6A2 (0.48) | SLC6A2SLC6A4KCNH2GABRA1GABRB2 | |
| SCHEMBL11991402 | 0.71 | SLC6A2 (0.50) | SLC6A2SLC6A4KCNH2GABRA1GABRB2 | |
| Hydrochloric Acid SCHEMBL9796807 | 0.71 | KCNN4 (0.36) | KCNH2CYP2D6SLC6A3L3MBTL1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2863875-A2 | MOUTH RINSE EMULSIONS | The Procter & Gamble Company (US) | 2015-04-29 | — | — | EP | claimed |
| WO-2013192382-A2 | MOUTH RINSE EMULSIONS | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-27 | — | — | WO | claimed |
| WO-2024123555-A2 | ANHYDROUS ORAL CARE COMPOSITIONS OF ADDUCTS OF ALKALI METAL PYROPHOSPHATES AND PEROXIDES | ISP INVESTMENTS LLC (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2022076334-A2 | CLEANING COMPOSITION COMPRISING AN ALPHA-DIOXYGENASE | THE PROCTER & GAMBLE COMPANY (US) | 2022-04-14 | — | — | WO | disclosed |
| WO-2021067683-A1 | CARBOMER BASED TOOTH PASTE COMPOSITION COMPRISING CROSSLINKED POLYVINYLPYRROLIDONE FOR BUILDING VISCOSITY | ISP INVESTMENTS LLC (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2020219323-A1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS | THE PROCTER & GAMBLE COMPANY (US) | 2020-10-29 | — | — | WO | disclosed |
| WO-2016073535-A1 | ANTI-TATAR ORAL CARE COMPOSITIONS PROVIDING CRYSTALLISATION PREVENTION | THE PROCTER & GAMBLE COMPANY (US) | 2016-05-12 | — | — | WO | disclosed |
| EP-2863875-A2 | MOUTH RINSE EMULSIONS | The Procter & Gamble Company (US) | 2015-04-29 | — | — | EP | disclosed |
| WO-2013192382-A2 | MOUTH RINSE EMULSIONS | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-27 | — | — | WO | disclosed |
| WO-2008042944-A2 | NON-IRRITATING ORAL CARE FORMULATIONS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2008-04-10 | — | — | WO | disclosed |
| EP-1545265-A1 | ORAL COMPOSITIONS AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2005-06-29 | — | — | EP | disclosed |
| EP-1545446-A1 | LIQUID DENTRIFICE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2005-06-29 | — | — | EP | disclosed |
| WO-2004032889-A1 | LIQUID DENTRIFICE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2004-04-22 | — | — | WO | disclosed |
| WO-2004032674-A1 | ORAL COMPOSITIONS AND USE THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2004-04-22 | — | — | WO | disclosed |
| WO-2002022096-A2 | ORAL COMPOSITIONS FOR MOISTRIZING THE ORAL CAVITY | THE PROCTER & GAMBLE COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |